Carebot AI Prostate Pathology is an innovative solution focused on the automatic detection and evaluation of histopathological indicators of prostate cancer using artificial intelligence. The project reflects the growing need for more accurate and effective diagnostics that would reduce human error and speed up the evaluation process. The product's development builds on previous experience with the detection of abnormalities in X-ray images and mammograms and is intended for healthcare facilities, laboratories, and clinical institutions. Its main competitive advantage is the possibility of integration into existing systems, such as PACS archives or clinical information systems, and in-depth know-how in the field of medical device certification. The project includes two business models: license fees for the use of the technology, including training and support, or direct sales of the software to healthcare companies for integration into their hardware devices. Financing is provided by private investors and Technological Incubation, which enables faster market launch. The project aims to first implement the technology on the domestic market, then expand into Europe with the ambition of becoming a leader in automated diagnostics in the CEE region and extending the solution to other areas of pathology.

Project leader: Carebot s.r.o.

This project was implemented with the financial support of the Technology Incubation program.